Speak directly and say only what you mean. Be loyal to the things you say you are going to do. Keep your promises.

The Future of Medicine is Here

Senior Scientific Director Jahda Hill, PhD, looks at how revolutionary therapeutic approaches are transforming the rare disease space. Read it now in the latest issue of PharmaVOICE:

Rare difficulties

Chris Tobias and Laurie Bartolomeo discuss the the greatest challenges facing rare disease marketers in the latest issue of PharmaVOICE.

Healthcare Agency Roundtable

Chris Tobias and Laurie Bartolomeo share their views on industry trends and developments in the MedAdNews annual report.

Optimizing marketing efforts for rare diseases

Laurie Bartolomeo talks to MM&M about the greatest challenge in rare disease marketing- finding patients.

Looking forward to 2019

Chris Tobias shares his thoughts on the trends we are tracking in the PharmaVOICE Year in Preview issue.

Dudnyk Saves Lives

Dudnyk donates two AED devices to Area Youth Facilities.

Dudnyk Pays it Forward

Dudnyk has implemented a major sustainable philanthropic initiative that allows employees to use their professional expertise and skills for the betterment of society. Laurie Bartolomeo discusses our charitable works in the October issue of PharmaVOICE.

The Patient Experience is not a Journey

The experience of so many patients today, those with rare, life-long, hereditary and even some chronic conditions, is not a linear journey with a beginning and an end. Lori Thatch, RN, contributes her thoughts on the Patient Experience to PM360.

The Agency of the Future

The advertising agency of the future may be more virtual than it is today, but the principles by which we work remain as important as ever. Chris Tobias shares his thoughts in the PharmaVOICE Agency Executive Roundtable.

Dudnyk Named PM360 Trailblazer Award Finalist in Multiple Categories

Dudnyk has been named a finalist in three different categories in the tenth annual PM360 Trailblazer Awards. The Trailblazer Awards are given to outstanding companies, marketers, and marketing teams for initiatives that represent the best of the healthcare marketing industry.

Dudnyk Gives Back –Simon’s Heart Campaign Kicks Off in Philly Mag

Dudnyk has partnered with Simon’s Heart, an organization that raises awareness about sudden cardiac arrest in children and offers free heart screenings that can detect underlying conditions. Giving back has always been a cornerstone of our agency culture, and this partnership, which will make a difference right here in our community, resulted in the creation of an emotional awareness campaign that launched this month in Philadelphia magazine.

Dudnyk Named a Best Place to Work

For the second year in a row, The Philadelphia Business Journal and Quantum Workplace have named Dudnyk a Best Place to Work.

Dudnyk Earns Multiple MM&M Award Nominations

Dudnyk earned five coveted spots on the Medical Marketing & Media (MM&M) Short List, including, for the third year in a row, Healthcare Agency of the Year.

Digital Dream Projects

PM360 asked marketers to share their digital dream projects. Drew Desjardins wants to see AR-aided rare disease diagnosis.

Client-Agency Relationships 101

Strong relationships require an investment of time, energy, and meaningful engagements. Annemarie Armstrong talks about the key to balancing client-agency relationships in PharmaVOICE.

How to succeed in a rapid-paced, ever-changing industry: my belief and advice to younger generations

President Christopher Tobias, PhD, shares the most important lessons he’s learned during his career so far.

Six Campaigns for Orphan Drugs That Use Real Patients as Advocates

In the May issue of MM&M, Dawn Hastings, associate creative director, takes a look at six campaigns for orphan drugs that use real patients as advocates.

MedAd News Annual Agency Issue

The much-anticipated annual agency issue of MedAd News included a terrific feature on Dudnyk.

From Bench to Bedside: Witnessing Firsthand the Power of Science to Transform Lives

When Jahda Hill, PhD, scientific director, left the lab to join Dudnyk, she never anticipated she would eventually work on the launch of the first therapy based on RNA interference—a scientific approach she used throughout her graduate and postdoctoral training.

Achieving authenticity with patients requires getting personal

The first time I met a person with a rare disease, I was young, less experienced, and completely unprepared for how the interaction would shape my perspective and ultimately lay the foundation for a career that would challenge and inspire me.